Stock-based compensation decreased 100.0%
Stock-based compensation changed -100.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stock-based compensation changed -100.0% from the comparable as-filed period.
Cash & equivalents changed +714.0% from the comparable as-filed period.
Inventory changed -45.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -95.7% from the comparable as-filed period.
Operating income changed -36.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -638 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +29.0% from the comparable as-filed period.
Revenue changed +16.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Selling, general & administrative changed +21.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed -251 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed +6.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.